{"log_id": 4863344586378188304, "direction": 0, "words_result_num": 30, "words_result": [{"probability": {"variance": 0.022941, "average": 0.919955, "min": 0.463766}, "location": {"width": 827, "top": 165, "height": 37, "left": 151}, "words": "中门付照多心研究,盐酸多柔比星脂质体组和ABV组每2周给药一次,最多6次该研"}, {"probability": {"variance": 0.008737, "average": 0.97101, "min": 0.46797}, "location": {"width": 828, "top": 213, "height": 40, "left": 151}, "words": "包1258名至重度卡波氏肉瘤患者(患者统计:男性98%,高加索人75%,平均年龄"}, {"probability": {"variance": 0.014454, "average": 0.950356, "min": 0.43551}, "location": {"width": 814, "top": 264, "height": 39, "left": 152}, "words": "38岁,同性恐>90%),用盐酸多柔比星脂质体ABV治疗的病人数分别为133和125例"}, {"probability": {"variance": 0.050876, "average": 0.854298, "min": 0.404361}, "location": {"width": 446, "top": 316, "height": 35, "left": 150}, "words": "和述究一样,大部分病人成为店不佳人群"}, {"probability": {"variance": 0.008217, "average": 0.977708, "min": 0.441768}, "location": {"width": 786, "top": 364, "height": 36, "left": 196}, "words": "主要的疗效终点指标基丁治疗的反应率(5个标准:完全缓解,临床完全缓解,部分缓"}, {"probability": {"variance": 0.017815, "average": 0.952582, "min": 0.374634}, "location": {"width": 833, "top": 414, "height": 37, "left": 148}, "words": "解,稳,疾病进展),而临床受益是建立在患者的癌性疼痛、与肿瘤相关的全身症状租体"}, {"probability": {"variance": 0.01002, "average": 0.971717, "min": 0.383131}, "location": {"width": 832, "top": 464, "height": 35, "left": 150}, "words": "、体力状况评分(KPS)和两种生活质量评分(QOL)基础上的评价。一项评价QOL的问卷专"}, {"probability": {"variance": 0.01461, "average": 0.965786, "min": 0.356282}, "location": {"width": 647, "top": 514, "height": 33, "left": 150}, "words": "门针对与艾病相关的卡波氏肉瘤,其它的评价采用了“药物疗效研究"}, {"probability": {"variance": 0.008427, "average": 0.973631, "min": 0.503858}, "location": {"width": 834, "top": 559, "height": 39, "left": 148}, "words": "Sudy获得的方法,该方法使用了“药物疗效研究“中的与HIV相关的项目,并通过比较"}, {"probability": {"variance": 0.004197, "average": 0.968129, "min": 0.745669}, "location": {"width": 556, "top": 614, "height": 32, "left": 151}, "words": "无症状HIV感染者和带有艾滋病相关综合症病人而得到验证"}, {"probability": {"variance": 7.5e-05, "average": 0.997191, "min": 0.946695}, "location": {"width": 789, "top": 660, "height": 36, "left": 195}, "words": "治疗终点的完全部分反应率证明了一个有利于盐酸多柔比星脂质体组的显著的统计学"}, {"probability": {"variance": 0.004182, "average": 0.972893, "min": 0.740269}, "location": {"width": 835, "top": 708, "height": 35, "left": 149}, "words": "差异,盐酸多柔比脂质体组利ABV组的反应率分别为46%和26%。两组缓解持续时间相"}, {"probability": {"variance": 0.014054, "average": 0.954557, "min": 0.428911}, "location": {"width": 854, "top": 755, "height": 37, "left": 151}, "words": "似(盐酸多柔比脂质体组与ABV组平均缓解持续时间分别为92.5天与84.8天,中位缓"}, {"probability": {"variance": 0.003487, "average": 0.980542, "min": 0.664784}, "location": {"width": 822, "top": 804, "height": 33, "left": 149}, "words": "解持续时间分别为90天与92大)除瘤体大小以外的其他病灶特征(如厚度、结节、水肿"}, {"probability": {"variance": 0.005402, "average": 0.977287, "min": 0.623723}, "location": {"width": 832, "top": 855, "height": 30, "left": 150}, "words": "颜色和疼痛)的结果表明与基值相比,两组均有所改善。死亡不是其中的一项研究终点,但"}, {"probability": {"variance": 0.001866, "average": 0.982695, "min": 0.776915}, "location": {"width": 563, "top": 903, "height": 34, "left": 149}, "words": "盐酸多柔比早脂质体的中位生存期为160天,ABV为153天"}, {"probability": {"variance": 0.002079, "average": 0.981692, "min": 0.820266}, "location": {"width": 787, "top": 951, "height": 30, "left": 197}, "words": "关于QOL答卷,在九个方面中有五个利于盐酸多柔比星脂质体组的统计学的显著差"}, {"probability": {"variance": 0.001111, "average": 0.990385, "min": 0.791216}, "location": {"width": 834, "top": 999, "height": 32, "left": 149}, "words": "异:总健康水平、疼痛、社交功能、体力水平和健康隐患。有关针对与卡波氏肉瘤相关的问"}, {"probability": {"variance": 0.003446, "average": 0.980975, "min": 0.65003}, "location": {"width": 832, "top": 1045, "height": 35, "left": 151}, "words": "苍,在九个方面中有四个有利于盐酸多柔比星脂质体组的显著统计学差异:肺功能障碍/疼"}, {"probability": {"variance": 0.002317, "average": 0.980031, "min": 0.793118}, "location": {"width": 455, "top": 1096, "height": 30, "left": 152}, "words": ",头部/肢体活动受限,运动受限以及睡眠障碍"}, {"probability": {"variance": 0.015734, "average": 0.952998, "min": 0.368193}, "location": {"width": 787, "top": 1144, "height": 30, "left": 198}, "words": "上所述,这一研究表明盐酸多柔比星脂质体与ABV方案有相同效果,在某些方面优"}, {"probability": {"variance": 0.004889, "average": 0.966662, "min": 0.667998}, "location": {"width": 831, "top": 1195, "height": 27, "left": 152}, "words": "ABV绢,如,疾病症状和容颜改善方面。尽管ABV组中没有一个药物是批准用来治疗"}, {"probability": {"variance": 0.014082, "average": 0.957366, "min": 0.385889}, "location": {"width": 835, "top": 1244, "height": 26, "left": 149}, "words": "AIDS-KS,但这种选择是较合理的,因为,它是目前公认的治疗晚期ADS-KS的有效组合"}, {"probability": {"variance": 0.001503, "average": 0.981658, "min": 0.82434}, "location": {"width": 788, "top": 1340, "height": 27, "left": 195}, "words": "阳性对照研究(30-11)设计为盐酸多柔比星脂质体组与BV组(博莱霉素与长春新碱)"}, {"probability": {"variance": 0.003766, "average": 0.986688, "min": 0.613587}, "location": {"width": 834, "top": 1390, "height": 27, "left": 151}, "words": "的随机比较试验。通过与已有治疗方法的比较来判断盐酸多柔比星脂质体对受试者的有效"}, {"probability": {"variance": 0.009098, "average": 0.965316, "min": 0.541024}, "location": {"width": 573, "top": 1439, "height": 25, "left": 149}, "words": "性,评价患有中至重度卡波氏肉瘤病人的用药安全性和耐受性"}, {"probability": {"variance": 0.00596, "average": 0.976438, "min": 0.604668}, "location": {"width": 785, "top": 1487, "height": 27, "left": 197}, "words": "共有241例中至重度卡波氏肉瘤病入参加,其中218例可用于疗效的评价。盐酸多柔"}, {"probability": {"variance": 0.010067, "average": 0.8821, "min": 0.724459}, "location": {"width": 159, "top": 1538, "height": 22, "left": 151}, "words": "比脂质体和BV"}, {"probability": {"variance": 0.020048, "average": 0.928883, "min": 0.425334}, "location": {"width": 590, "top": 1535, "height": 27, "left": 390}, "words": "n博莱霉素1.4mg/m2长春新碱)均为静脉给药,盐酸多柔比"}, {"probability": {"variance": 0.017442, "average": 0.94164, "min": 0.47308}, "location": {"width": 606, "top": 1583, "height": 26, "left": 147}, "words": "脂质体每周给药一次,剂量为20mg/m2,BV组治疗周期为三周"}], "language": 3}